11/12/2025
๐๐ก๐จ๐ฎ๐ฅ๐ ๐ ๐๐ ๐จ๐ง ๐๐๐ซ๐๐ฏ๐ฎ๐ฌ ๐๐ง๐ ๐๐๐ฌ๐ข๐ฆ๐ฉ๐ญ๐? With so many new treatments for Multiple Sclerosis (MS), choosing the right one can feel overwhelming. Ocrevus and Kesimpta both target the same B-cell pathway, yet they differ in how theyโre administered and who theyโre best suited for. Ocrevus remains the only approved option for Primary Progressive MS, while Kesimpta offers convenient at-home injections for those with relapsing forms. Understanding these differencesโand coming prepared with questionsโcan help you and your doctor make the best decision for your care.
At BeCare MS, weโre here to help you stay informed, track your disease progression, and connect with a supportive community of MS patients and resources. Be empowered. Be a driver in your own MS journey.
Read more: https://becarelink.com/should-i-be-on-ocrevus-and-kesimpta/